lecanemab
eisai
['lecanemab']
why are we not more concerned about the loss of brain volume in #alzheimers amyloid immunotherapies? plenary says it is a loss of 3 tablespoons of brain. clinically significant? time and better studies may inform? 
National Medical Advisor @parkinsondotorg 
Author 14 books https://t.co/EJCwDpEIw8 blog
Professor @UF @fixelinstitute
@DBSThinkTank